Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
BMC Research Notes
|
August 14, 2012
Undergraduate medical students' perceptions, attitudes, and competencies in evidence-based medicine (EBM), and their understanding of EBM reality in Syria
Fares Alahdab, Belal Firwana, Rim Hasan, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
December 31, 2024
Body mass index as a prognostic indicator of overall survival in glioblastoma: A systematic review and meta analysis
Preston Carey, Christopher Gardner, Adam Uppendahl, et al.
Neuro-Oncology Advances
|
March 6, 2026
Metformin exposure after glioblastoma diagnosis and mortality: A large population-based study
Vittorio Maio, Roshani Shah, Manisha Lin, et al.
Chinese Clinical Oncology
|
July 7, 2023
Differences in clinical outcomes based on molecular markers in glioblastoma patients treated with concurrent tumor-treating fields and chemoradiation: exploratory analysis of the SPARE trial
Louis Cappelli, Mehak Majid Khan, Allison Kayne, et al.
Neuro-Oncology Advances
|
July 14, 2021
Erratum to: Characterizing Benefit from Temozolomide in MGMT Promoter Unmethylated and Methylated Glioblastoma: A Systematic Review and Meta-analysis
Iyad Alnahhas, Mouaz Alsawas, Appaji Rayi, et al.
Neuro-Oncology Advances
|
November 5, 2020
Characterizing benefit from temozolomide in MGMT promoter unmethylated and methylated glioblastoma: a systematic review and meta-analysis
Iyad Alnahhas, Mouaz Alsawas, Appaji Rayi, et al.
Cancers
|
February 6, 2019
Treatment of Glioblastoma (GBM) with the Addition of Tumor-Treating Fields (TTF): A Review
Denise Fabian, Maria Del Pilar Guillermo Prieto Eibl, Iyad Alnahhas, et al.
Neuro-Oncology Advances
|
June 27, 2025
Primary central nervous system lymphoma: Predictors of response to induction therapy and patterns of progression
Louis Cappelli, Allison Kayne, Jennifer Newman, et al.
Neuro-Oncology Advances
|
May 14, 2026
MGMTai: O6-methylguanine-DNA methyltransferase (<i>MGMT</i>) methylation prediction in isocitrate dehydrogenase (<i>IDH</i>)-wild type glioblastoma to direct temozolomide therapy
Patricia Pittman, Chen Sun, Timothy Samec, et al.
Journal of Neuro-Oncology
|
November 10, 2022
Concurrent chemoradiation and Tumor Treating Fields (TTFields, 200 kHz) for patients with newly diagnosed glioblastoma: patterns of progression in a single institution pilot study
Ayesha S Ali, Joseph Lombardo, Muneeb Z Niazi, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
BMC Research Notes
|
August 14, 2012
Undergraduate medical students' perceptions, attitudes, and competencies in evidence-based medicine (EBM), and their understanding of EBM reality in Syria
Fares Alahdab, Belal Firwana, Rim Hasan, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
December 31, 2024
Body mass index as a prognostic indicator of overall survival in glioblastoma: A systematic review and meta analysis
Preston Carey, Christopher Gardner, Adam Uppendahl, et al.
Neuro-Oncology Advances
|
March 6, 2026
Metformin exposure after glioblastoma diagnosis and mortality: A large population-based study
Vittorio Maio, Roshani Shah, Manisha Lin, et al.
Chinese Clinical Oncology
|
July 7, 2023
Differences in clinical outcomes based on molecular markers in glioblastoma patients treated with concurrent tumor-treating fields and chemoradiation: exploratory analysis of the SPARE trial
Louis Cappelli, Mehak Majid Khan, Allison Kayne, et al.
Neuro-Oncology Advances
|
July 14, 2021
Erratum to: Characterizing Benefit from Temozolomide in MGMT Promoter Unmethylated and Methylated Glioblastoma: A Systematic Review and Meta-analysis
Iyad Alnahhas, Mouaz Alsawas, Appaji Rayi, et al.
Neuro-Oncology Advances
|
November 5, 2020
Characterizing benefit from temozolomide in MGMT promoter unmethylated and methylated glioblastoma: a systematic review and meta-analysis
Iyad Alnahhas, Mouaz Alsawas, Appaji Rayi, et al.
Cancers
|
February 6, 2019
Treatment of Glioblastoma (GBM) with the Addition of Tumor-Treating Fields (TTF): A Review
Denise Fabian, Maria Del Pilar Guillermo Prieto Eibl, Iyad Alnahhas, et al.
Neuro-Oncology Advances
|
June 27, 2025
Primary central nervous system lymphoma: Predictors of response to induction therapy and patterns of progression
Louis Cappelli, Allison Kayne, Jennifer Newman, et al.
Neuro-Oncology Advances
|
May 14, 2026
MGMTai: O6-methylguanine-DNA methyltransferase (<i>MGMT</i>) methylation prediction in isocitrate dehydrogenase (<i>IDH</i>)-wild type glioblastoma to direct temozolomide therapy
Patricia Pittman, Chen Sun, Timothy Samec, et al.
Journal of Neuro-Oncology
|
November 10, 2022
Concurrent chemoradiation and Tumor Treating Fields (TTFields, 200 kHz) for patients with newly diagnosed glioblastoma: patterns of progression in a single institution pilot study
Ayesha S Ali, Joseph Lombardo, Muneeb Z Niazi, et al.
Page
of 3